A prospective interventional study to assess role of an integrated approach of Homoeopathy along with WHO Rehabilitation self-management care for long COVID: Single blind placebo controlled randomized trial

Central Council for Research in Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年5月29日

试验速览

暂无简介。

•History of confirmed COVID-19 infection in last 6 months; Minimum 4 weeks after the confirmed COVID-19 report.
•Residual or any other clinical complaints reported to be occurring after COVID-19 like fatigue, fever (unknown reason), anxiety, joint pain, breathlessness, headache, or any other non-serious clinical illness not explained by an alternative diagnosis.
•Cases who have recovered clinically&/or laboratory confirmed negative.
•Patients agreeing to perform WHO self-care rehabilitation program under guidance of the physician.
•Patients willing to participate in the study and give written informed consent

•Patients having any serious sequelae, presence of systemic complications (persistent organic damage) or specific organ dysfunction due to SARS-CoV-2 virus.
•Uncontrolled cases of DM, HT, Asthma, HIV, active TB, Cancer, immune compromised illness like HIV etc.
•Patients having severe dyspnoea with Oxygen saturation below 95%; patients requiring ventilation support
•Patient reporting having Psychiatric disorders, hepatic and renal dysfunction.
•Contra indications to physical exercise or Patient unable to do exercise in the WHO rehabilitation self-management care plan.
•Patients not able to give written informed consent

发起方

Central Council for Research in Homoeopathy